+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Emergency Contraceptive Pills Market by Type, Category, Age Group, Distribution - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896594
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Emergency Contraceptive Pills Market grew from USD 1.02 billion in 2023 to USD 1.08 billion in 2024. It is expected to continue growing at a CAGR of 6.49%, reaching USD 1.58 billion by 2030.

The market for emergency contraceptive pills (ECPs) is witnessing dynamic changes, propelled by increasing awareness and evolving societal attitudes towards family planning and reproductive health. Defined as medications intended to prevent pregnancy after unprotected sex or contraceptive failure, ECPs cover hormonal pills like Plan B and Ella. The necessity for these pills stems from rising incidents of unintended pregnancies, heightened awareness regarding reproductive rights, and supportive government policies in various regions. The application of ECPs is primarily focused on the prevention of pregnancy, with hospitals, clinics, and pharmacies being the primary end-use channels. One of the pivotal growth factors is the growing public awareness facilitated by governmental and non-governmental initiatives. Furthermore, the expansion of e-commerce platforms aids accessibility, driving the market forward.

Recent trends point towards opportunities in personalized healthcare services and the integration of telemedicine with contraceptive counseling, making it possible to cater to diverse demographic segments more effectively. However, several challenges persist, including cultural and religious opposition, misconceptions regarding the safety and side effects of ECPs, and regulatory hurdles in certain regions, which can hinder market growth. Moreover, market players must navigate competitive pricing strategies due to the availability of over-the-counter options.

Innovation opportunities include research in developing formulations with fewer side effects, longer windows of efficacy post-incident, and improved accessibility in low-income regions. There's potential in leveraging technology for better education and outreach programs, thus fostering informed decision-making. Additionally, partnerships with health tech firms for enhanced distribution and user engagement could prove beneficial. The nature of the ECP market is competitive yet ripe for innovation, calling for a strategic approach to addressing societal and regulatory challenges while capitalizing on technological advancements to ensure broader access and acceptance.

Understanding Market Dynamics in the Emergency Contraceptive Pills Market

The Emergency Contraceptive Pills Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising adoption owing to unintended pregnancies in the U.S.
    • Government initiatives to promote use of contraceptive pills
  • Market Restraints
    • Issues regarding the effectiveness and incidences of recall of emergency contraceptive pills
  • Market Opportunities
    • Increasing R&D and collaborative awareness campaigns by manufacturers
    • Easy availability through online channel
  • Market Challenges
    • Probable side effects associated with consuming emergency contraceptive pills

Exploring Porter’s Five Forces for the Emergency Contraceptive Pills Market

Porter’s Five Forces framework further strengthens the insights of the Emergency Contraceptive Pills Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Emergency Contraceptive Pills Market

External macro-environmental factors deeply influence the performance of the Emergency Contraceptive Pills Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Emergency Contraceptive Pills Market

The Emergency Contraceptive Pills Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Emergency Contraceptive Pills Market

The Emergency Contraceptive Pills Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Emergency Contraceptive Pills Market

The Emergency Contraceptive Pills Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Emergency Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Curae Pharma360 Inc., Foundation Consumer Healthcare, LLC, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer, Inc., Piramal Enterprises Ltd., Rapha Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Viatris Inc., Wockhardt USA LLC, and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Emergency Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Antiprogestin
    • Combination Pills
    • Progesterone Pills
  • Category
    • Branded
    • Generic
  • Age Group
    • 15-24
    • 25-34
    • 35-44
    • 45 and Above
  • Distribution
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Emergency Contraceptive Pills Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption owing to unintended pregnancies in the U.S.
5.1.1.2. Government initiatives to promote use of contraceptive pills
5.1.2. Restraints
5.1.2.1. Issues regarding the effectiveness and incidences of recall of emergency contraceptive pills
5.1.3. Opportunities
5.1.3.1. Increasing R&D and collaborative awareness campaigns by manufacturers
5.1.3.2. Easy availability through online channel
5.1.4. Challenges
5.1.4.1. Probable side effects associated with consuming emergency contraceptive pills
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Emergency Contraceptive Pills Market, by Type
6.1. Introduction
6.2. Antiprogestin
6.3. Combination Pills
6.4. Progesterone Pills
7. Emergency Contraceptive Pills Market, by Category
7.1. Introduction
7.2. Branded
7.3. Generic
8. Emergency Contraceptive Pills Market, by Age Group
8.1. Introduction
8.2. 15-24
8.3. 25-34
8.4. 35-44
8.5. 45 and Above
9. Emergency Contraceptive Pills Market, by Distribution
9.1. Introduction
9.2. Offline
9.3. Online
10. Americas Emergency Contraceptive Pills Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Emergency Contraceptive Pills Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Emergency Contraceptive Pills Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Gedeon Richter Acquires Oral Contraceptive Range from Consilient Health
13.3.1.2. Health-Care Startup Up Acquires Patient Records of Bankrupt Birth Control Provider
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Government of the United States Signed an Executive Order Expanding Access to Birth Control
13.3.3. New Product Launch & Enhancement
13.3.3.1. Morning After Pill Brand Speeds Up Retail Access, Doubles Supply Per Pack
13.3.3.2. Curae Pharma360 Launches OTC Emergency Contraception to Advance Equitable, Reliable Access to Medicines; Partners with Direct Relief to Reach Underserved Women
13.3.3.3. Lupin Launches Generic Contraceptive Drug Merzee Capsules in U.S.
13.3.4. Award, Recognition, & Expansion
13.3.4.1. Aurobindo Pharma Receives USFDA Nod for Contraceptives
13.3.4.2. Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AbbVie Inc.
14.1.2. Afaxys Pharma, LLC
14.1.3. Amneal Pharmaceuticals, Inc.
14.1.4. Apotex Inc.
14.1.5. Aurobindo Pharma Limited
14.1.6. Bayer AG
14.1.7. Bionpharma Inc.
14.1.8. Cipla Limited
14.1.9. Combe Incorporated
14.1.10. Curae Pharma360 Inc.
14.1.11. Foundation Consumer Healthcare, LLC
14.1.12. Gedeon Richter PLC
14.1.13. Glenmark Pharmaceuticals Limited
14.1.14. Julie Product Inc.
14.1.15. Lupin Limited
14.1.16. Mankind Pharma Ltd.
14.1.17. Merck & Co., Inc.
14.1.18. Northstar Rx LLC
14.1.19. Perrigo Company plc
14.1.20. Pfizer, Inc.
14.1.21. Piramal Enterprises Ltd.
14.1.22. Rapha Pharmaceuticals, Inc.
14.1.23. Sun Pharmaceutical Industries Limited
14.1.24. Syzygy Healthcare Solutions, LLC
14.1.25. Viatris Inc.
14.1.26. Wockhardt USA LLC
14.1.27. Xiromed, LLC
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. EMERGENCY CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
FIGURE 2. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
FIGURE 3. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EMERGENCY CONTRACEPTIVE PILLS MARKET DYNAMICS
FIGURE 7. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
FIGURE 10. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 12. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 14. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

The leading players in the Emergency Contraceptive Pills Market, which are profiled in this report, include:
  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bionpharma Inc.
  • Cipla Limited
  • Combe Incorporated
  • Curae Pharma360 Inc.
  • Foundation Consumer Healthcare, LLC
  • Gedeon Richter PLC
  • Glenmark Pharmaceuticals Limited
  • Julie Product Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Merck & Co., Inc.
  • Northstar Rx LLC
  • Perrigo Company plc
  • Pfizer, Inc.
  • Piramal Enterprises Ltd.
  • Rapha Pharmaceuticals, Inc.
  • Sun Pharmaceutical Industries Limited
  • Syzygy Healthcare Solutions, LLC
  • Viatris Inc.
  • Wockhardt USA LLC
  • Xiromed, LLC

Methodology

Loading
LOADING...

Table Information